25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner

[1]  Lindsey A. Muir,et al.  Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes , 2020, Molecular metabolism.

[2]  Steve Lianoglou,et al.  TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.

[3]  U. Andley,et al.  Mechanism of Action of VP1-001 in cryAB(R120G)-Associated and Age-Related Cataracts , 2019, Investigative ophthalmology & visual science.

[4]  S. Natesan,et al.  Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response , 2019, Nature Communications.

[5]  Genetic,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[6]  Nick C Fox,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[7]  H. Gurvit,et al.  Association between selected cholesterol-related gene polymorphisms and Alzheimer’s disease in a Turkish cohort , 2019, Molecular Biology Reports.

[8]  Timothy J. Hohman,et al.  Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.

[9]  D. Holtzman,et al.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight , 2018, Nature Reviews Immunology.

[10]  I. Amit,et al.  Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration , 2018, Cell.

[11]  W. Möbius,et al.  Defective cholesterol clearance limits remyelination in the aged central nervous system , 2018, Science.

[12]  Melanie A. Huntley,et al.  Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse Models. , 2018, Cell reports.

[13]  R. Marioni,et al.  GWAS on family history of Alzheimer’s disease , 2018, bioRxiv.

[14]  D. Russell,et al.  Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation , 2017, Cell.

[15]  A. Fagan,et al.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy , 2017, Nature.

[16]  Markus Glatzel,et al.  The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.

[17]  J. Levin,et al.  RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease , 2017, Proceedings of the National Academy of Sciences.

[18]  P. Deyn,et al.  Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease , 2017, Neurobiology of Aging.

[19]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[20]  Wei Tang,et al.  APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer’s disease progression: A comparative study based on Han and She populations in the Wenzhou area , 2017, Brain Research Bulletin.

[21]  M. T. Hasan,et al.  Cellular cholesterol homeostasis and Alzheimer’s disease , 2017, Journal of Lipid Research.

[22]  G. Rebeck,et al.  The role of APOE on lipid homeostasis and inflammation in normal brains , 2017, Journal of Lipid Research.

[23]  D. Holtzman,et al.  Apolipoprotein E and Alzheimer’s disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins , 2017, Journal of Lipid Research.

[24]  Hoon-Chul Kang,et al.  25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome , 2016, Nature Communications.

[25]  S. Hiller,et al.  ASC filament formation serves as a signal amplification mechanism for inflammasomes , 2016, Nature Communications.

[26]  I. Olsen,et al.  Inflammasome Involvement in Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[27]  G. Poli,et al.  Oxysterols: An emerging class of broad spectrum antiviral effectors. , 2016, Molecular aspects of medicine.

[28]  G. Muscat,et al.  RORα and 25-Hydroxycholesterol Crosstalk Regulates Lipid Droplet Homeostasis in Macrophages , 2016, PloS one.

[29]  J. El Khoury,et al.  β-amyloid, microglia, and the inflammasome in Alzheimer’s disease , 2015, Seminars in Immunopathology.

[30]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[31]  S. Paul,et al.  Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody , 2015, Scientific Reports.

[32]  Jeremy A. Miller,et al.  Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis , 2015, Acta Neuropathologica Communications.

[33]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[34]  K. Takahara,et al.  Amyloid β oligomers induce interleukin-1β production in primary microglia in a cathepsin B- and reactive oxygen species-dependent manner. , 2015, Biochemical and biophysical research communications.

[35]  M. Heneka,et al.  Innate immunity in Alzheimer's disease , 2015, Nature Immunology.

[36]  F. Edwards,et al.  A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.

[37]  E. Hol,et al.  Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction , 2014, Neurobiology of Aging.

[38]  J. Cyster,et al.  25-Hydroxycholesterols in innate and adaptive immunity , 2014, Nature Reviews Immunology.

[39]  J. Cidlowski,et al.  One Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids , 2014, Neuroimmunomodulation.

[40]  D. Russell,et al.  25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferon , 2014, Science.

[41]  E. Gold,et al.  25-Hydroxycholesterol acts as an amplifier of inflammatory signaling , 2014, Proceedings of the National Academy of Sciences.

[42]  P. Blackshear,et al.  APOε4 is associated with enhanced in vivo innate immune responses in human subjects. , 2014, The Journal of allergy and clinical immunology.

[43]  M. LaDu,et al.  Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition , 2014, Journal of Neuroinflammation.

[44]  Christine E. Becker,et al.  CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation , 2013, Nature Immunology.

[45]  D. Brody,et al.  Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice. , 2013, Journal of neuropathology and experimental neurology.

[46]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[47]  G. Cheng,et al.  Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. , 2013, Immunity.

[48]  N. Karin,et al.  The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications , 2013, Journal of leukocyte biology.

[49]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[50]  S. Dumanis,et al.  APOE genotype alters glial activation and loss of synaptic markers in mice , 2012, Glia.

[51]  Guojun Bu,et al.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[52]  Eric M. Blalock,et al.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease , 2011, Journal of Chemical Neuroanatomy.

[53]  R. Tanzi,et al.  Age-Dependent Effect of Apolipoprotein E4 on Functional Outcome after Controlled Cortical Impact in Mice , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  G. Rimbach,et al.  Implications of apolipoprotein E genotype on inflammation and vitamin E status. , 2010, Molecular nutrition & food research.

[55]  D. Golenbock,et al.  Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide , 2009, Journal of Lipid Research.

[56]  D. Russell,et al.  25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production , 2009, Proceedings of the National Academy of Sciences.

[57]  Carol A. Colton,et al.  APOE genotype-specific differences in the innate immune response , 2009, Neurobiology of Aging.

[58]  S. Coons,et al.  APOE 4 polymorphism results in early cognitive deficits in an EAE model. , 2009, Biochemical and biophysical research communications.

[59]  J. Goldstein,et al.  Erratum: Cholesterol feedback: From Schoenheimer's bottle to Scap's MELADL (Journal of Lipid Research (2009) 50 (S15-S27)) , 2009 .

[60]  M. Burns,et al.  Low‐density lipoprotein receptors regulate microglial inflammation through c‐Jun N‐terminal kinase , 2009, Glia.

[61]  D. Blacker,et al.  Assessment of Alzheimer’s disease case–control associations using family-based methods , 2009, neurogenetics.

[62]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[63]  S. Andersson,et al.  Neuronal expression and subcellular localization of cholesterol 24‐hydroxylase in the mouse brain , 2008, The Journal of comparative neurology.

[64]  M. Gill,et al.  Association studies of 23 positional/functional candidate genes on chromosome 10 in late‐onset Alzheimer's disease , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[65]  P. Charifson,et al.  (S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Act , 2007, Journal of Pharmacology and Experimental Therapeutics.

[66]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[67]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[68]  Hartwig Wolburg,et al.  Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology , 2006, EMBO reports.

[69]  D. Covey,et al.  Synthesis of ent-25-hydroxycholesterol , 2006, Steroids.

[70]  David Walker,et al.  Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus , 2006, The Journal of Neuroscience.

[71]  H. Braak,et al.  Cholesterol 25-Hydroxylase on Chromosome 10q Is a Susceptibility Gene for Sporadic Alzheimer’s Disease , 2006, Neurodegenerative Diseases.

[72]  Joseph L. Goldstein,et al.  Protein Sensors for Membrane Sterols , 2006, Cell.

[73]  R. Mayeux,et al.  Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease , 2006, Neuroscience Letters.

[74]  O. Levi,et al.  Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation , 2005, Journal of neurochemistry.

[75]  Christopher M. Adams,et al.  Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and Insigs* , 2004, Journal of Biological Chemistry.

[76]  N. Klopp,et al.  Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer’s disease , 2004, Neurobiology of Aging.

[77]  M. Vitek,et al.  APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response* , 2003, Journal of Biological Chemistry.

[78]  D. Russell.  The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[79]  C. Colton,et al.  APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress , 2002, Neurobiology of Aging.

[80]  B. Ohlsson,et al.  Oxysterols induce interleukin‐1β production in human macrophages , 2002, European journal of clinical investigation.

[81]  L. Lue,et al.  Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia , 2001, Neurobiology of Aging.

[82]  D. Russell,et al.  Oxysterol biosynthetic enzymes. , 2000, Biochimica et biophysica acta.

[83]  A. Goate,et al.  Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease , 2000, Neurology.

[84]  L. V. Van Eldik,et al.  β-Amyloid Stimulation of Inducible Nitric-oxide Synthase in Astrocytes Is Interleukin-1β- and Tumor Necrosis Factor-α (TNFα)-dependent, and Involves a TNFα Receptor-associated Factor- and NFκB-inducing Kinase-dependent Signaling Mechanism* , 2000, The Journal of Biological Chemistry.

[85]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[86]  D. Russell,et al.  cDNA Cloning of Mouse and Human Cholesterol 25-Hydroxylases, Polytopic Membrane Proteins That Synthesize a Potent Oxysterol Regulator of Lipid Metabolism* , 1998, The Journal of Biological Chemistry.

[87]  N. Maeda,et al.  Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.

[88]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[89]  Peter Riederer,et al.  Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients , 1995, Neuroscience Letters.

[90]  R. Mrak,et al.  Glial cytokines in Alzheimer's disease: review and pathogenic implications. , 1995, Human pathology.

[91]  R. Cacabelos,et al.  Interleukin-1 in Alzheimer's disease and multi-infarct dementia: neuropsychological correlations. , 1991, Methods and findings in experimental and clinical pharmacology.

[92]  B. Kottke,et al.  Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells. , 1989, The Biochemical journal.

[93]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[94]  R. E. Pitas,et al.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.

[95]  M. Brown,et al.  Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. , 1974, The Journal of biological chemistry.

[96]  A. Kandutsch,et al.  Inhibition of sterol synthesis in cultured mouse cells by cholesterol derivatives oxygenated in the side chain. , 1974, The Journal of biological chemistry.

[97]  V Huynh Tien‐Phat,et al.  ApoE and Lipid Homeostasis in Alzheimer's Disease Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-.BETA. and other amyloidogenic proteins , 2017 .

[98]  A. Sailer,et al.  Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity. , 2015, Journal of autoimmunity.

[99]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[100]  S. Heath,et al.  Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study. , 2010, Journal of Alzheimer's disease : JAD.

[101]  G. Landreth,et al.  Toll-like receptors in Alzheimer's disease. , 2009, Current topics in microbiology and immunology.

[102]  Chiou-Lian Lai,et al.  PARKINSON’S DISEASE PATIENTS , 2008 .

[103]  L. J. Eldik,et al.  A dual role for apolipoprotein E in neuroinflammation , 2007, Journal of Molecular Neuroscience.

[104]  V. Mathura,et al.  Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. , 2005, Journal of neuroinflammation.

[105]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[106]  G. Schroepfer,et al.  Oxysterols: modulators of cholesterol metabolism and other processes. , 2000, Physiological reviews.

[107]  P Riederer,et al.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. , 1995, Neuroscience letters.